CPHI South East Asia 2018 was grandly held at Jakarta International Convention and Exhibition Center on March 27-29, 2018. With the rapid development of the ASEAN market, the trade scale of pharmaceutical products between China and ASEAN is increasing day by day. ASEAN has become the second largest market for China's medical and health products export. The exhibition attracted many enterprises to actively participate. High quality visitors, hundreds of key decision makers and buyers of pharmaceutical enterprises gathered together to look for opportunities to purchase pharmaceutical raw materials, packaging and devices in large quantities, as well as international partners who can establish long-term and stable cooperative relations.
In order to further develop the ASEAN market, President Xie and President Hu of the company participated in the 2018 CPHI Indonesia Exhibition on behalf of the company, comprehensively displayed the company's new products and development direction in recent years, and conducted in-depth exchanges and communication with new and old customers at home and abroad, laying a good foundation for further cooperation. During the three-day exhibition, an endless stream of customers came to visit and communicate with the company's booth, which further expanded the influence of biopurify brand in the Southeast Asian market, achieved good results and achieved the expected results. It has also taken another solid step in the internationalization process of the "biopurify" brand.The following are the pictures of the exhibition site:
